Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarwish Rafiq

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Molecular Therapy. Oncology|September 30, 2024
Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancerHeather K Lin, Dejah A Blake, Tongrui Liu, et al.
Ebiomedicine|December 24, 2018
Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemiaChun-Hui Jin, Jinxing Xia, Sarwish Rafiq, et al.
Cancer Immunology Research|March 27, 2020
Optimization of T-cell Receptor-Modified T Cells for Cancer TherapyDylan J Drakes, Sarwish Rafiq, Terence J Purdon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2013
Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage propertiesSarwish Rafiq, Jonathan P Butchar, Carolyn Cheney, et al.
Advanced Healthcare Materials|March 10, 2021
Engineered Cytokines for Cancer and Autoimmune Disease ImmunotherapyBiaggio Uricoli, Lacey A Birnbaum, Priscilla Do, et al.
Mabs|March 6, 2014
Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemiaCarolyn M Cheney, Deborah M Stephens, Xiaokui Mo, et al.
Nature Communications|December 9, 2020
Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophagesMei Song, Oladapo O Yeku, Sarwish Rafiq, et al.
Blood|March 22, 2014
Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicityHolbrook E Kohrt, Idit Sagiv-Barfi, Sarwish Rafiq, et al.
Molecular Therapy. Oncology|September 23, 2024
TYRP1 directed CAR T cells control tumor progression in preclinical melanoma modelsChristopher S Hackett, Daniel Hirschhorn, Meixian S Tang, et al.
Advanced Healthcare Materials|January 21, 2024
Engineering Improved CAR T Cell Products with A Multi-Cytokine Particle Platform for Hematologic and Solid TumorsHeather K Lin, Biaggio Uricoli, Ruby Freeman, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Molecular Therapy. Oncology|September 30, 2024
Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancerHeather K Lin, Dejah A Blake, Tongrui Liu, et al.
Ebiomedicine|December 24, 2018
Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemiaChun-Hui Jin, Jinxing Xia, Sarwish Rafiq, et al.
Cancer Immunology Research|March 27, 2020
Optimization of T-cell Receptor-Modified T Cells for Cancer TherapyDylan J Drakes, Sarwish Rafiq, Terence J Purdon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 19, 2013
Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage propertiesSarwish Rafiq, Jonathan P Butchar, Carolyn Cheney, et al.
Advanced Healthcare Materials|March 10, 2021
Engineered Cytokines for Cancer and Autoimmune Disease ImmunotherapyBiaggio Uricoli, Lacey A Birnbaum, Priscilla Do, et al.
Mabs|March 6, 2014
Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemiaCarolyn M Cheney, Deborah M Stephens, Xiaokui Mo, et al.
Nature Communications|December 9, 2020
Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophagesMei Song, Oladapo O Yeku, Sarwish Rafiq, et al.
Blood|March 22, 2014
Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicityHolbrook E Kohrt, Idit Sagiv-Barfi, Sarwish Rafiq, et al.
Molecular Therapy. Oncology|September 23, 2024
TYRP1 directed CAR T cells control tumor progression in preclinical melanoma modelsChristopher S Hackett, Daniel Hirschhorn, Meixian S Tang, et al.
Advanced Healthcare Materials|January 21, 2024
Engineering Improved CAR T Cell Products with A Multi-Cytokine Particle Platform for Hematologic and Solid TumorsHeather K Lin, Biaggio Uricoli, Ruby Freeman, et al.
Pageof 3